Modern medical knowledge and ethics are firmly rooted in Greek and Latin wisdom, and still today these languages profoundly influence medical and pharmaceutical terminology. Our founder chose the name Triclinium for two reasons. Firstly, the obvious alliterative association with our core business (Trials, Clinical). Secondly as an indirect but apt symbol for our logo.

Triclinium is the Latin word for dining-room. In the patrician villas of Rome, this room had tables and couches along three (“tri”) sides, with the fourth side open for servants bringing food and wine.

Our logo turns the three-sided table on its side, but instead of a meal, we deliver to our clients the three key elements of a successful clinical trial – Sites, Monitors and Data – brought together in the mathematical symbol of summation, the Greek letter Sigma (Σ).

The symbolism in not entirely abstract: we do appreciate epicurean pleasures, but we do not dine out at our clients’ expense.

“Pharmaceutical companies are increasingly choosing smaller CROs, which can carry out assignments satisfactorily at a competitive price”
– CentreWatch 7:5, May 2000

“Increasingly, small to mid-sized CROs are forming global joint ventures to extend the reach required in modern pharmaceutical, biotechnology and medical device development.”
– John V Farinacci, International Clinical Trials, 2006

“A sponsor company needs to know that both its team and the CRO’s team share the same values, work ethics and general approaches.”
– Harold E Glass, Inside Outsourcing, 2007

“South Africa has close on three decades of clinical research experience. Some of the large evolving research regions of the world do not have as long a heritage of Good Clinical Practice as South Africa has at both investigator and study management levels.”
– Victor Strugo, CentreWatch 12:3, March 2005

“South Africa is the best gateway to researching sub-Saharan African populations. Until experience in research management grows in those countries, trials initiated in the region are most competently and economically monitored from South Africa.”
– Victor Strugo, CentreWatch 12:3, March 2005

“A 2001 survey conducted by CentreWatch, a US information services company for the clinical trials industry, “demonstrated that small and mid-sized CROs are typically deemed more responsive, more accessible and less bureaucratic, with higher staff retention rates.”
– Scrip 2665, Aug 1, 2001